Patents by Inventor Sylvie Lecoustey

Sylvie Lecoustey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GAMMA-HYDROXYBUTYRIC ACID GRANULES
    Publication number: 20180193277
    Abstract: A granule including a solid core on which is supported an active ingredient, said active ingredient being selected from gamma-hydroxybutric acid or one of its pharmaceutically acceptable salts, said granule further including, supported on said solid core, one or more compounds which may generate gas evolvement, one or more diluents, said granule being in that it is coated with a membrane, and in that the solid core represents from 15% to 25% by weight based on the total weight of the granule.
    Type: Application
    Filed: March 6, 2018
    Publication date: July 12, 2018
    Applicant: DEBREGEAS ET ASSOCIES PHARMA
    Inventors: Pascal SUPLIE, Sylvie LECOUSTEY
  • Gamma hydroxybutyric acid granules
    Patent number: 9943488
    Abstract: A granule including a solid core on which is supported an active ingredient, said active ingredient being selected from gamma-hydroxybutric acid or one of its pharmaceutically acceptable salts, said granule further including, supported on said solid core, one or more compounds which may generate gas evolvement, one or more diluents, said granule being in that it is coated with a membrane, and in that the solid core represents from 15% to 50% by weight based on the total weight of the granule.
    Type: Grant
    Filed: February 3, 2012
    Date of Patent: April 17, 2018
    Assignee: DEBREGEAS ET ASSOCIES PHARMA
    Inventors: Pascal Suplie, Sylvie Lecoustey
  • GAMMA-HYDROXYBUTYRIC ACID GRANULES
    Publication number: 20140004202
    Abstract: A granule including a solid core on which is supported an active ingredient, said active ingredient being selected from gamma-hydroxybutric acid or one of its pharmaceutically acceptable salts, said granule further including, supported on said solid core, one or more compounds which may generate gas evolvement, one or more diluents, said granule being in that it is coated with a membrane, and in that the solid core represents from 15% to 50% by weight based on the total weight of the granule.
    Type: Application
    Filed: February 3, 2012
    Publication date: January 2, 2014
    Applicant: DEBREGEAS ET ASSOCIES PHARMA
    Inventors: Pascal Suplie, Sylvie Lecoustey